2025
March 19: Our lab is thrilled to announce the receipt of an NIH R01 grant to advance our research on acute myeloid leukemia, driving new discoveries in leukemia biology and therapeutic strategies.
March 12: We are delighted to have our manuscript selected by our institute as 'Manuscript of the Year' for 2024.
2024
May 22: John presented our work on the role of chromatin deregulation in CEBPA mutant AML at the International Workshop on Myeloid Stem Cell Development and Leukemia at Cincinnati.
Mar 1: Our manuscript investigating the role of the N-MYC/ eIF4G1 axis in inv(16) AML, led by Sona, was published in Science Advances. Special thanks to lab members Sona Peramangalam, Sridevi Surapally, Anthony Veltri, Shikan Zheng, and our collaborators. Congratulations!
Jan 1: American Cancer Society awarded a Research Scholar Grant to Pulikkan Lab!
2023
Mar 10: Our manuscript under review on the role of N-MYC in inv(16) leukemogenesis has been posted at bioRxiv.
Feb 16: A co-authored paper with Dr. Daniel G Tenen (Harvard Medical School) is published in Blood on the role of ADAR2 RNA editing in AML leukemogenesis. Congratulations!
2022
Dec 12: Sridevi presented our work on the role of the N-MYC/ eIF4G1 axis in inv(16) leukemogenesis at the American Society of Hematology Annual Meeting at New Orleans.
May 25: John presented our work on the role of the N-MYC/ eIF4G1 axis in inv(16) leukemogenesis at the International Workshop on Myeloid Stem Cell Development and Leukemia at Cincinnati.
2021
June 23: Medical College of Wisconsin Cancer Center, in association with the American Cancer Society, awarded an Institutional Research Grant to Pulikkan Lab!
May 19: A co-authored paper with Dr. Philipp Staber (University of Vienna) is published in Blood on the role of PU.1 antisense promoter in core binding factor leukemia. Congratulations!
May 13: First Lab Publication! Review manuscript in Blood on emerging therapies for inv(16) AML. Congratulations!
March 31: Congratulations to Sid Rao lab for their publication in Scientific Reports on DOT1L inhibitors block abnormal self-renewal induced by cohesin loss.
2020
February 10: Sridevi Surapally joined the lab as a postdoctoral fellow.
2019
July 12: Big congrats to Dr. Richard Aster from our institute on receiving the Wallace H. Coulter Award for Lifetime Achievement in Hematology from the American Society of Hematology (ASH).
January 23: Congratulations to Roy Silverstein from our institute on being elected as President of the American Society of Hematology (ASH).
2018
December 17: Philomina Sona joined the lab as a Research Technologist.
December 13: John presented his work at Department of Cell Biology, Neurobiology and Anatomy (CBNA) at Medical College of Wisconsin. The title of the presentation is “Hematopoietic Gene Regulation: From Transcription Factors to Chromatin Dynamics.
November 18: Pulikkan lab is awarded a $1 million financial support from the Stollenwerk Family Foundation. We are thrilled and honored to receive this support!
October 30: An editorial by Constanze Bonifer and colleagues published in Stem Cell Investigation about John’s recent manuscript published in Cell.
October 14: John presented his work at Alex Lemonade Stand Foundation Young Investigator meeting at Milwaukee. The title of the presentation is “From Basic Science to Drug Discovery: Development of CBFβ-SMMHC Inhibitor in the Treatment of inv(16) Leukemia”.
October 8: Pulikkan Lab started at Versiti Blood Research Institute, Medical College of Wisconsin, Milwaukee.
